Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cross Country Healthcare ( (CCRN) ) has shared an update.
On December 9, 2025, Cross Country Healthcare held its Annual Meeting of Stockholders where several key proposals were voted on. The stockholders approved the election of directors for a one-year term, ratified the appointment of Deloitte & Touche as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and approved the compensation of named executive officers on an advisory basis.
The most recent analyst rating on (CCRN) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.
Spark’s Take on CCRN Stock
According to Spark, TipRanks’ AI Analyst, CCRN is a Neutral.
Cross Country Healthcare’s overall stock score is primarily impacted by its financial performance challenges, including declining revenue and profitability issues. The bearish technical indicators further weigh on the score. Valuation concerns, highlighted by a negative P/E ratio, also contribute to the lower score. The termination of the merger adds uncertainty, although the company shows some financial resilience through planned share repurchases.
To see Spark’s full report on CCRN stock, click here.
More about Cross Country Healthcare
Average Trading Volume: 658,897
Technical Sentiment Signal: Sell
Current Market Cap: $260.4M
Find detailed analytics on CCRN stock on TipRanks’ Stock Analysis page.